Levodopa-induced dyskinesias in the absence of nigrostriatal degeneration

被引：6

作者：

Bezard, Erwan ^{[1
,2
]}

Olanow, C. Warren ^{[3
,4
]}

Obeso, Jose A. ^{[5
,6
,7
]}

机构：

[1] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France

[2] CNRS, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France

[3] Mt Sinai Sch Med, Dept Neurol, New York, NY USA

[4] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA

[5] Univ Navarra, Movement Disorders Grp, Ctr Appl Med Res, Neurosci Div, E-31080 Pamplona, Spain

[6] Univ Navarra, Dept Neurol & Neurosurg, Univ Clin, E-31080 Pamplona, Spain

[7] Univ Navarra, Ctr Networked Biomed Res Neurodegenerat Dis CIBER, E-31080 Pamplona, Spain

来源：

MOVEMENT DISORDERS | 2013年 / 28卷 / 08期

关键词：

DOPA-INDUCED DYSKINESIA; PARKINSONS-DISEASE; RECEPTOR EXPRESSION; NEUROTROPHIC FACTOR; MECHANISMS; NEURONS;

D O I：

10.1002/mds.25533

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1023 / 1024

页数：2

共 16 条

[1] Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies [J].

Bezard, E ;

Brotchie, JM ;

Gross, CE .

NATURE REVIEWS NEUROSCIENCE, 2001, 2 (08) :577-588

[2] CONTRIBUTION OF PRE-SYNAPTIC MECHANISMS TO L-DOPA-INDUCED DYSKINESIA [J].

Carta, M. ;

Bezard, E. .

NEUROSCIENCE, 2011, 198 :245-251

[3] DOPAMINE NEURON GLUTAMATE COTRANSMISSION: FREQUENCY-DEPENDENT MODULATION IN THE MESOVENTROMEDIAL PROJECTION [J].

Chuhma, N. ;

Choi, W. Y. ;

Mingote, S. ;

Rayport, S. .

NEUROSCIENCE, 2009, 164 (03) :1068-1083

[4] MODIFICATION OF PARKINSONISM - CHRONIC TREATMENT WITH L-DOPA [J].

COTZIAS, GC ;

PAPAVASI.PS ;

GELLENE, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (07) :337-&

[5] BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization [J].

Guillin, O ;

Diaz, J ;

Carroll, P ;

Griffon, N ;

Schwartz, JC ;

Sokoloff, P .

NATURE, 2001, 411 (6833) :86-89

[6] Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease [J].

Guillin, O ;

Griffon, N ;

Bezard, E ;

Leriche, L ;

Diaz, J ;

Gross, C ;

Sokoloff, P .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 480 (1-3) :89-95

[7] The long-term response to levodopa in dopa-responsive dystonia [J].

Hwang, WJ ;

Calne, DB ;

Tsui, JKC ;

de la Fuente-Fernández, R .

PARKINSONISM & RELATED DISORDERS, 2001, 8 (01) :1-5

[8] Molecular mechanisms of L-DOPA-induced dyskinesia [J].

Jenner, Peter .

NATURE REVIEWS NEUROSCIENCE, 2008, 9 (09) :665-677

[9] Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications [J].

Olanow, C. Warren ;

Obeso, Jose A. ;

Stocchi, Fabrizio .

LANCET NEUROLOGY, 2006, 5 (08) :677-687

[10]

Olanow CW, 2013, MOV DISORD

← 1 2 →